Morgan Stanley »

Onkure Therapeutics Inc-a shares owned by Morgan Stanley

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $59k 14k 4.14
2025-12-31 $72k 25k 2.90
2025-09-30 $47k 17k 2.75
2025-06-30 $40k 17k 2.39
2024-12-31 $8.0k 932 8.60

More positions owned by Morgan Stanley

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)

View all positions for Morgan Stanley

Top funds holding Onkure Therapeutics Inc-a

RA Capital Management
Acorn Capital Advisors
StepStone
ADAR1 Capital Management
BVF
Vivo Capital
Vestal Point Capital
Foresite Capital Management VI
Prosight Management
Rosalind Advisors
Vanguard Group
Vanguard Capital Management
Highbridge Capital Management
NEA Management Company
Carlyle

View all funds holding Onkure Therapeutics Inc-a